Effects of atorvastatin on inflammatorymarkers, lipid profile, liver enzymes,and pulmonary function in patients with lungdiseases: a systematic reviewand meta-analysis of randomizedcontrolled trials
Atorvastatin demonstrates anti-inflammatory and lipid-lowering efficacy in pulmonary disease patients, with mild functional respiratory benefits and modest improvements in physical performance. Additional large-scale studies are needed to validate clinical benefits and effective treatment methods.
Authors
- Mina Alimohammadi (ORCID: https://orcid.org/0000-0002-5953-3894)
- Seyedeh Mahdieh Khoshnazar (ORCID: https://orcid.org/0000-0002-5394-5660)
- Kiavash Hushmandi
- Morteza Izadi
- Samane Baseri
- Reza Nikdel
Institutions
- Baqiyatallah University of Medical Sciences (IR)
- Kerman University of Medical Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1186/s40001-025-03782-y
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00